Catalog No.
PHG32101
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human DPYD (Ile781-Cys1025).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
Dihydropyrimidine dehydrogenase [NADP(+)], DPYD, DPD, Dihydrouracil dehydrogenase, Dihydrothymine dehydrogenase, DHPDHase
Purification
Purified by antigen affinity column.
Accession
Q12882
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review., PMID:39931054
Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC., PMID:36432658
Modern developments in germline pharmacogenomics for oncology prescribing., PMID:35302652
Evaluating genomic biomarkers associated with resistance or sensitivity to chemotherapy in patients with advanced breast and colorectal cancer., PMID:32847480
Anti-TSNARE1 IgG plasma levels differ by sex in patients with schizophrenia in a Chinese population., PMID:31336035
Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy., PMID:30114658
Study of Novel Autoantibodies in Schizophrenia., PMID:29373732
Genotypes Affecting the Pharmacokinetics of Anticancer Drugs., PMID:27641154
Uncommon dihydropyrimidine dehydrogenase mutations and toxicity by fluoropyrimidines: a lethal case with a new variant., PMID:26651493
Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study., PMID:26372896
The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III., PMID:24007863
Pharmacogenetics in chemotherapy of colorectal cancer., PMID:19414151
For research use only. Not for human or drug use.
